Purple Biotech Ltd (TLV:PPBT)
Israel · Delayed Price · Currency is ILS · Price in ILA 1.000
0.00 (0.00%)
Jun 2, 2026, 10:54 AM IDT
Purple Biotech Market Cap
Purple Biotech has a market cap or net worth of 18.65 million as of June 4, 2026. Its market cap has decreased by -30.97% in one year.
Market Cap
18.65M
Enterprise Value
-1.25M
Revenue
n/a
Ranking
n/a
PE Ratio
n/a
Stock Price
1.00
Market Cap Chart
Since July 14, 2013, Purple Biotech's market cap has increased from 17.87M to 18.65M, an increase of 4.32%. That is a compound annual growth rate of 0.33%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jun 2, 2026 | 18.65M | -16.39% |
| Dec 31, 2025 | 22.30M | -44.71% |
| Dec 31, 2024 | 40.34M | -48.30% |
| Dec 31, 2023 | 78.02M | -17.30% |
| Dec 29, 2022 | 94.35M | -55.64% |
| Dec 30, 2021 | 212.71M | -1.36% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Bonus BioGroup | 443.89M |
| Geffen Residence & Renewal | 322.52M |
| Matricelf | 84.25M |
| Clal Biotechnology Industries | 44.70M |
| BioLineRx | 41.94M |
| BioLight Life Sciences | 29.82M |
| Can-Fite BioPharma | 19.78M |
| Evogene | 17.70M |